Adrafinil (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Adrafinil" in English language version.

refsWebsite

Global rank English rank

9nih.gov

4^th place

8doi.org

2^nd place

6books.google.com

3^rd place

5web.archive.org

1^st place

5semanticscholar.org

11^th place

8^th place

5fda.gov

447^th place

338^th place

1sante.fr

8,603^rd place

low place

1bloomberg.com

99^th place

77^th place

1wada-ama.org

9,542^nd place

8,313^th place

1regulations.gov

low place

1opss.org

low place

1medsafe.govt.nz

low place

bloomberg.com (Global: 99^th place; English: 77^th place)

"Stocks". Bloomberg.com. 2023-05-24. Retrieved 2023-05-24.

books.google.com (Global: 3^rd place; English: 3^rd place)

Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. pp. 20–. ISBN 978-3-88763-075-1.
Kleemann A, Engel J, Kutscher B, Reichert D, Kleemann A, Engel J, et al. (2009). Pharmaceutical Substances (5th: Syntheses, Patents and Applications of the most relevant APIs ed.). Georg Thieme Verlag. ISBN 978-3-13-179525-0.
Aronson JK (31 December 2012). Side Effects of Drugs Annual: A worldwide yearly survey of new data in adverse drug reactions. Newnes. pp. 6–. ISBN 978-0-444-59503-4.
Schatzberg AF, Nemeroff CB (2009). The American Psychiatric Publishing Textbook of Psychopharmacology. American Psychiatric Pub. pp. 850–. ISBN 978-1-58562-309-9.
Guglietta A (28 November 2014). Drug Treatment of Sleep Disorders. Springer. pp. 212–. ISBN 978-3-319-11514-6.
Li JJ, Johnson DS (27 March 2013). Modern Drug Synthesis. John Wiley & Sons. pp. 2–. ISBN 978-1-118-70124-9.

doi.org (Global: 2^nd place; English: 2^nd place)

Robertson P, Hellriegel ET (2003). "Clinical pharmacokinetic profile of modafinil". Clin Pharmacokinet. 42 (2): 123–37. doi:10.2165/00003088-200342020-00002. PMID 12537513. S2CID 1266677.
Milgram N (1999). "Adrafinil: A Novel Vigilance Promoting Agent". CNS Drug Reviews. 5 (3): 193–212. doi:10.1111/j.1527-3458.1999.tb00100.x.
Thobois S, Xie J, Mollion H, Benatru I, Broussolle E (2004). "Adrafinil-induced orofacial dyskinesia". Mov. Disord. 19 (8): 965–6. doi:10.1002/mds.20154. PMID 15300665. S2CID 31816404.
Simon P, Chermat R, Puech AJ (1983). "Pharmacological evidence of the stimulation of central alpha-adrenergic receptors". Prog. Neuropsychopharmacol. Biol. Psychiatry. 7 (2–3): 183–6. doi:10.1016/0278-5846(83)90105-7. PMID 6310690. S2CID 45147850.
Zolkowska D, Jain R, Rothman RB, Partilla JS, Roth BL, Setola V, Prisinzano TE, Baumann MH (May 2009). "Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil". The Journal of Pharmacology and Experimental Therapeutics. 329 (2): 738–46. doi:10.1124/jpet.108.146142. PMC 2672878. PMID 19197004.
Reith ME, Blough BE, Hong WC, Jones KT, Schmitt KC, Baumann MH, Partilla JS, Rothman RB, Katz JL (Feb 2015). "Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter". Drug and Alcohol Dependence. 147: 1–19. doi:10.1016/j.drugalcdep.2014.12.005. PMC 4297708. PMID 25548026.
Quisenberry AJ, Baker LE (Dec 2015). "Dopaminergic mediation of the discriminative stimulus functions of modafinil in rats". Psychopharmacology. 232 (24): 4411–9. doi:10.1007/s00213-015-4065-0. PMID 26374456. S2CID 15519396.
Ballas CA, Kim D, Baldassano CF, Hoeh N (July 2002). "Modafinil: past, present and future". Expert Review of Neurotherapeutics. 2 (4): 449–457. doi:10.1586/14737175.2.4.449. PMID 19810941. S2CID 32939239.

fda.gov (Global: 447^th place; English: 338^th place)

fda.gov

"Peak Nootropics LLC aka Advanced Nootropics - 557887 - 02/05/2019". Center for Food Safety and Applied Nutrition (CFSAN). U.S. Food and Drug Administration. 2019-12-20. Retrieved 2023-05-05.
Office of Regulatory Affairs (2019-12-20). "Hermitage Man Sentenced for Importing and Selling Drugs Not Approved by FDA". U.S. Department of Justice – via U.S. Food and Drug Administration.^{[dead link]}
"Fort Collins Couple Sentenced to Federal Prison for Illegally Selling Unapproved Drugs". Food and Drug Administration. FDA Office of Criminal Investigations. June 10, 2022. Archived from the original on June 14, 2022. Retrieved May 21, 2023.
"Arizona Company and CEO Plead Guilty to the Distribution of Drugs Not Approved by the FDA and Will Pay $2.4 Million". Food and Drug Administration. FDA Office of Criminal Investigations. October 30, 2023. Archived from the original on October 31, 2023. Retrieved November 6, 2023.

accessdata.fda.gov

"Import Alert 54-16". www.accessdata.fda.gov. Archived from the original on January 10, 2015. Retrieved 2023-05-22.

medsafe.govt.nz (Global: low place; English: low place)

"MCC Minutes Out of Session Meeting". Medsafe.govt.nz. 23 May 2013. Retrieved 18 December 2013.

nih.gov (Global: 4^th place; English: 4^th place)

pubmed.ncbi.nlm.nih.gov

Robertson P, Hellriegel ET (2003). "Clinical pharmacokinetic profile of modafinil". Clin Pharmacokinet. 42 (2): 123–37. doi:10.2165/00003088-200342020-00002. PMID 12537513. S2CID 1266677.
Thobois S, Xie J, Mollion H, Benatru I, Broussolle E (2004). "Adrafinil-induced orofacial dyskinesia". Mov. Disord. 19 (8): 965–6. doi:10.1002/mds.20154. PMID 15300665. S2CID 31816404.
Simon P, Chermat R, Puech AJ (1983). "Pharmacological evidence of the stimulation of central alpha-adrenergic receptors". Prog. Neuropsychopharmacol. Biol. Psychiatry. 7 (2–3): 183–6. doi:10.1016/0278-5846(83)90105-7. PMID 6310690. S2CID 45147850.
Zolkowska D, Jain R, Rothman RB, Partilla JS, Roth BL, Setola V, Prisinzano TE, Baumann MH (May 2009). "Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil". The Journal of Pharmacology and Experimental Therapeutics. 329 (2): 738–46. doi:10.1124/jpet.108.146142. PMC 2672878. PMID 19197004.
Reith ME, Blough BE, Hong WC, Jones KT, Schmitt KC, Baumann MH, Partilla JS, Rothman RB, Katz JL (Feb 2015). "Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter". Drug and Alcohol Dependence. 147: 1–19. doi:10.1016/j.drugalcdep.2014.12.005. PMC 4297708. PMID 25548026.
Quisenberry AJ, Baker LE (Dec 2015). "Dopaminergic mediation of the discriminative stimulus functions of modafinil in rats". Psychopharmacology. 232 (24): 4411–9. doi:10.1007/s00213-015-4065-0. PMID 26374456. S2CID 15519396.
Ballas CA, Kim D, Baldassano CF, Hoeh N (July 2002). "Modafinil: past, present and future". Expert Review of Neurotherapeutics. 2 (4): 449–457. doi:10.1586/14737175.2.4.449. PMID 19810941. S2CID 32939239.

ncbi.nlm.nih.gov

Zolkowska D, Jain R, Rothman RB, Partilla JS, Roth BL, Setola V, Prisinzano TE, Baumann MH (May 2009). "Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil". The Journal of Pharmacology and Experimental Therapeutics. 329 (2): 738–46. doi:10.1124/jpet.108.146142. PMC 2672878. PMID 19197004.
Reith ME, Blough BE, Hong WC, Jones KT, Schmitt KC, Baumann MH, Partilla JS, Rothman RB, Katz JL (Feb 2015). "Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter". Drug and Alcohol Dependence. 147: 1–19. doi:10.1016/j.drugalcdep.2014.12.005. PMC 4297708. PMID 25548026.

opss.org (Global: low place; English: low place)

"DOD PROHIBITED DIETARY SUPPLEMENT INGREDIENTS". Operation Supplement Safety. Retrieved 2023-05-31.

regulations.gov (Global: low place; English: low place)

"Regulations.gov". www.regulations.gov. Retrieved 2023-05-20.

sante.fr (Global: 8,603^rd place; English: low place)

ansm.sante.fr

AFSSAPS (2011). "Point d'information sur les dossiers discutés en commission d'AMM Séance du jeudi 1er décembre 2011 - Communiqué". Archived from the original on 13 September 2017.

semanticscholar.org (Global: 11^th place; English: 8^th place)

api.semanticscholar.org

Robertson P, Hellriegel ET (2003). "Clinical pharmacokinetic profile of modafinil". Clin Pharmacokinet. 42 (2): 123–37. doi:10.2165/00003088-200342020-00002. PMID 12537513. S2CID 1266677.
Thobois S, Xie J, Mollion H, Benatru I, Broussolle E (2004). "Adrafinil-induced orofacial dyskinesia". Mov. Disord. 19 (8): 965–6. doi:10.1002/mds.20154. PMID 15300665. S2CID 31816404.
Simon P, Chermat R, Puech AJ (1983). "Pharmacological evidence of the stimulation of central alpha-adrenergic receptors". Prog. Neuropsychopharmacol. Biol. Psychiatry. 7 (2–3): 183–6. doi:10.1016/0278-5846(83)90105-7. PMID 6310690. S2CID 45147850.
Quisenberry AJ, Baker LE (Dec 2015). "Dopaminergic mediation of the discriminative stimulus functions of modafinil in rats". Psychopharmacology. 232 (24): 4411–9. doi:10.1007/s00213-015-4065-0. PMID 26374456. S2CID 15519396.
Ballas CA, Kim D, Baldassano CF, Hoeh N (July 2002). "Modafinil: past, present and future". Expert Review of Neurotherapeutics. 2 (4): 449–457. doi:10.1586/14737175.2.4.449. PMID 19810941. S2CID 32939239.

wada-ama.org (Global: 9,542^nd place; English: 8,313^th place)

"Prohibited List" (PDF). World Anti-Doping Agency. 2007. Archived from the original (PDF) on 2009-04-10.

web.archive.org (Global: 1^st place; English: 1^st place)

"Fort Collins Couple Sentenced to Federal Prison for Illegally Selling Unapproved Drugs". Food and Drug Administration. FDA Office of Criminal Investigations. June 10, 2022. Archived from the original on June 14, 2022. Retrieved May 21, 2023.
"Arizona Company and CEO Plead Guilty to the Distribution of Drugs Not Approved by the FDA and Will Pay $2.4 Million". Food and Drug Administration. FDA Office of Criminal Investigations. October 30, 2023. Archived from the original on October 31, 2023. Retrieved November 6, 2023.
AFSSAPS (2011). "Point d'information sur les dossiers discutés en commission d'AMM Séance du jeudi 1er décembre 2011 - Communiqué". Archived from the original on 13 September 2017.
"Prohibited List" (PDF). World Anti-Doping Agency. 2007. Archived from the original (PDF) on 2009-04-10.
"Import Alert 54-16". www.accessdata.fda.gov. Archived from the original on January 10, 2015. Retrieved 2023-05-22.

Adrafinil (English Wikipedia)

bloomberg.com (Global: 99th place; English: 77th place)

books.google.com (Global: 3rd place; English: 3rd place)

doi.org (Global: 2nd place; English: 2nd place)

fda.gov (Global: 447th place; English: 338th place)

fda.gov

accessdata.fda.gov

medsafe.govt.nz (Global: low place; English: low place)

nih.gov (Global: 4th place; English: 4th place)

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

opss.org (Global: low place; English: low place)

regulations.gov (Global: low place; English: low place)

sante.fr (Global: 8,603rd place; English: low place)

ansm.sante.fr

semanticscholar.org (Global: 11th place; English: 8th place)

api.semanticscholar.org

wada-ama.org (Global: 9,542nd place; English: 8,313th place)

web.archive.org (Global: 1st place; English: 1st place)

bloomberg.com (Global: 99^th place; English: 77^th place)

books.google.com (Global: 3^rd place; English: 3^rd place)

doi.org (Global: 2^nd place; English: 2^nd place)

fda.gov (Global: 447^th place; English: 338^th place)

nih.gov (Global: 4^th place; English: 4^th place)

sante.fr (Global: 8,603^rd place; English: low place)

semanticscholar.org (Global: 11^th place; English: 8^th place)

wada-ama.org (Global: 9,542^nd place; English: 8,313^th place)

web.archive.org (Global: 1^st place; English: 1^st place)